Espoo, Finland

Päivi Granvik

This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Päivi Granvik. Retrieved from https://idiyas.com/inventor/päivi-granvik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Solutions by Päivi Granvik

Introduction

Päivi Granvik is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions for intravenous administration. His work focuses on enhancing the stability of pharmaceutical solutions, which is crucial for effective medical treatments.

Latest Patents

Granvik holds a patent for "Pharmaceutical solutions of levosimendan." This invention specifically addresses levosimendan solutions for pharmaceutical use, particularly for intravenous administration. The solutions developed by Granvik exhibit enhanced stability, making them particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is recognized for its effectiveness in treating congestive heart failure, highlighting the importance of Granvik's work in improving patient care.

Career Highlights

Päivi Granvik is associated with Orion Corporation, a leading company in the pharmaceutical industry. His role at Orion has allowed him to focus on innovative solutions that address critical health issues. Granvik's dedication to research and development has positioned him as a key figure in the advancement of pharmaceutical technologies.

Collaborations

Granvik has collaborated with esteemed colleagues such as Reijo Bäckström and Ritva Haikala. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of their research and development efforts.

Conclusion

Päivi Granvik's contributions to pharmaceutical solutions, particularly through his patent on levosimendan solutions, demonstrate his commitment to improving healthcare. His work at Orion Corporation and collaborations with fellow researchers underscore the importance of innovation in the medical field. Granvik's efforts are paving the way for more effective treatments for patients suffering from congestive heart failure.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…